GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R109. A total of 11 filers reported holding GENETIC TECHNOLOGIES LTD in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $8,000 | -81.0% | 19,694 | -73.3% | 0.00% | -100.0% |
| Q3 2014 | $42,000 | +55.6% | 73,744 | +190.7% | 0.00% | – |
| Q2 2014 | $27,000 | -68.2% | 25,368 | -58.3% | 0.00% | -100.0% |
| Q1 2014 | $85,000 | +174.2% | 60,872 | +186.9% | 0.00% | – |
| Q4 2013 | $31,000 | +24.0% | 21,220 | +96.4% | 0.00% | – |
| Q3 2013 | $25,000 | – | 10,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Partners USVI, LLC | 11,100 | $16,000 | 0.08% |
| Tower Research Capital LLC (TRC) | 1,634 | $2,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 400 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 21,220 | $31,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 10 | $0 | 0.00% |
| CITIGROUP INC | 261 | $0 | 0.00% |